CogniCurrent Icon

COGNICURRENT

A compact global news feed for the bigger picture.

⌕
Regions
Topics
Saved views:
Save your current filters to revisit or share.
32 stories
🇰🇷 Hankyoreh (KR)
National & Local

China Grants First Commercial Approval for ‘Brain Implant’ for Patients with Spinal Cord Injury and Limb Paralysis

China has become the first country to commercially approve a brain-computer interface device designed to assist patients with spinal cord injuries and limb paralysis.

Mar 23 • 01:04 UTC
🇪🇸 El País
National & Local

National Lottery: check the draw of Thursday, March 19

Spain's National Lottery has a draw scheduled for March 19, 2026, featuring a top prize of 30,000 euros per ticket and celebrating the 35th anniversary of the Association of People with Spinal Cord Injury of Madrid.

Mar 19 • 20:17 UTC
🇸🇪 Aftonbladet
National & Local

Paralyzed individuals controlled a keyboard with their thoughts

Researchers have enabled paralyzed individuals to write on a screen using only their thoughts through an advanced brain-computer interface.

Mar 17 • 18:07 UTC
🇫🇮 Iltalehti
Life & Tech

True Story: Neurologist Changed Treatment in the 1940s – The Consequences Can Be Seen This Friday on TV

The article discusses the impact of neurologist Ludwig Guttmann's revolutionary treatment methods for spinal cord injury patients in the 1940s, as highlighted in the film 'The Best of Men', coinciding with the current Winter Paralympics.

Mar 13 • 03:00 UTC
🇧🇷 G1 (PT)
Life & Tech

Polylaminin: why the study was not published by scientific journals and what the next steps of the research are

The study on polylaminin has faced publication rejection from scientific journals due to discrepancies in patient recovery rates and the lack of prior registration in an international research database.

Mar 11 • 08:02 UTC
🇧🇷 G1 (PT)
National & Local

The first to receive polylaminin in MG, woman says the medication is 'a sign of hope'

A woman from Governador Valadares, Brazil, became the first in Minas Gerais to receive an experimental treatment aimed at regenerating nerve connections after a spinal cord injury.

Mar 8 • 16:12 UTC
🇧🇷 Folha (PT)
National & Local

'Rehabilitation is decisive and cannot be sidelined in studies with polylaminin,' says doctor

A Brazilian doctor emphasizes the importance of prioritizing rehabilitation in the clinical studies of polylaminin, a substance being tested for acute spinal cord injury treatment.

Mar 8 • 02:00 UTC
🇧🇷 Folha (PT)
National & Local

Article about polylaminin has errors and will be revised, says researcher to newspaper

Biologist Tatiana Coelho de Sampaio announces that errors in a pre-print article on polylaminin as a treatment for spinal cord injury will be corrected before resubmission to scientific journals.

Mar 7 • 22:57 UTC
🇧🇷 G1 (PT)
National & Local

Patient who lost movement receives treatment with polylaminin in Salvador: 'Rekindled my faith'

A 38-year-old logistics operator in Salvador receives an experimental treatment for spinal cord injury using polylaminin at a private hospital, marking a significant step in medical research in Brazil.

Mar 7 • 10:00 UTC
🇧🇷 G1 (PT)
National & Local

Polilaminin: hospital in the interior of SP provides placentas for the production of a substance tested in the treatment of spinal cord injuries

A hospital in Itapira, São Paulo, is collecting placenta donations to produce polilaminin, a substance currently being tested for the treatment of acute spinal cord injuries.

Mar 7 • 08:01 UTC
🇧🇷 G1 (PT)
National & Local

Ethics Committee of HC-USP denies experimental use of polylaminin on sergeant who was shot and injured spinal cord

The Medical Ethics Committee at the Hospital das Clínicas, USP, denied the request for experimental treatment with polylaminin for a police sergeant who suffered a severe spinal cord injury.

Mar 6 • 13:42 UTC
🇧🇷 G1 (PT)
National & Local

Tatiana Sampaio, researcher of polylaminin, will be honored by Alerj

Tatiana Sampaio, a researcher from UFRJ, will receive the Benemérita title from the State of Rio de Janeiro for her work on polylaminin, an experimental substance for spinal cord injury treatment.

Mar 5 • 17:36 UTC
🇧🇷 G1 (PT)
National & Local

'I want to be like before,' says the 1st young person from MT to receive polylaminin in experimental study

'I want to be like before,' says a 21-year-old from Rondonópolis, Brazil who is the first in his state to participate in an experimental treatment for spinal cord injuries using polylaminin.

Mar 3 • 15:33 UTC
🇧🇷 G1 (PT)
National & Local

Polylaminin is not yet a drug: specialists warn against 'hype' on social media

Experts caution that the biotechnological compound polylaminin, popularized for its potential in treating spinal cord injuries, is still unproven and should not be considered a cure.

Mar 1 • 08:01 UTC
🇧🇷 G1 (PT)
National & Local

Use of polylaminin is monitored in real time by society: 'Like a Big Brother', says researcher

Research on polylaminin, a substance being studied as a possible treatment for spinal cord injuries, is closely monitored by society, according to lead researcher Tatiana Sampaio.

Feb 27 • 18:24 UTC
🇧🇷 Folha (PT)
National & Local

How long will it take for us to know the effectiveness of polylaminin? Understand the substance in 16 topics

Polylaminin has generated significant attention on social media due to its association with reports of patient recovery, but experts urge caution due to a lack of robust clinical evidence supporting its efficacy and safety.

Feb 25 • 21:45 UTC
🇧🇷 G1 (PT)
National & Local

Delegate who survived accident with police vehicle receives dose of polylaminin in an attempt to walk again

Delegate Leonardo Sanches, paralyzed after a car accident, has received polylaminin treatment, becoming the first individual in Goiás to access this potentially life-altering therapy.

Feb 25 • 11:45 UTC
🇧🇷 G1 (PT)
National & Local

Polylaminin: How the studies were conducted, what are the results so far, and what does Anvisa say? Understand

A groundbreaking Brazilian study on polylaminin shows promising results in restoring movement after severe injuries, with a pivotal clinical study approved by Anvisa set to begin next month.

Feb 25 • 03:01 UTC
🇧🇷 Folha (PT)
National & Local

'Self-promotion with little scientific methodology', says reader about medication for patients with spinal cord injury

A reader critiques the promotion of a medication for spinal cord injury patients, arguing it lacks sufficient scientific backing.

Feb 24 • 23:55 UTC
🇧🇷 Folha (PT)
National & Local

Neurologists alert to lack of evidence on the action of poly-L-lysine in spinal cord injury

Brazilian neurologists warn about insufficient scientific evidence supporting the use of poly-L-lysine for treating spinal cord injuries in humans.

Feb 23 • 18:04 UTC
🇧🇷 G1 (PT)
National & Local

Polylaminin: Maranhão native who received the substance begins home treatment and shows improvement

Hector Lucena, a 26-year-old agronomy student from Balsas, Maranhão, has begun at-home treatment with polylaminin for spinal cord trauma and reports improvements in his health.

Feb 23 • 17:28 UTC
🇧🇷 G1 (PT)
National & Local

VIDEO: Reporter Flávia Cintra hugs biologist Tatiana Sampaio, researcher leading studies on polylaminin

Reporter Flávia Cintra shares an emotional moment with biologist Tatiana Sampaio during a segment on the substance polylaminin, which offers hope for those with spinal cord injuries, going viral on social media.

Feb 23 • 14:26 UTC
🇧🇷 G1 (PT)
National & Local

This is Fantastic: the advances in experimental treatments with polylaminin

The article discusses promising advancements in experimental treatments involving polylaminin, a placenta-derived protein that may restore movement in patients with severe spinal cord injuries.

Feb 22 • 20:39 UTC
🇧🇷 G1 (PT)
National & Local

VIDEO: João Gomes interrupts show in Sapucaí to honor scientist leading research on polylaminin

Singer João Gomes interrupted a performance to pay tribute to researcher Tatiana Sampaio, who is recognized for her work on polylaminin for treating acute spinal cord injuries.

Feb 22 • 16:50 UTC
🇧🇷 Folha (PT)
National & Local

Scientific societies call for caution and precision in the debate over poly-laminin

Scientific societies in Brazil urge caution in the discussion surrounding poly-laminin, a protein under investigation for spinal cord injury regeneration, emphasizing the importance of distinguishing experimental research from established clinical application.

Feb 21 • 15:51 UTC
🇧🇷 Folha (PT)
National & Local

Polylaminin and Tatiana Sampaio go viral on social media, but fall well below Virginia, says survey

Biologist Tatiana Sampaio has gained 16 million interactions on social media, receiving significant attention for her research on polylaminin, a protein aimed at aiding spinal cord injury regeneration.

Feb 20 • 19:21 UTC
🇧🇷 G1 (PT)
National & Local

Patient walks again and polylaminin trends; understand what the substance can do and what is still unknown

Polylaminin has recently gained attention on social media due to a patient's recovery and ongoing discussions about its potential and patent issues in Brazil.

Feb 20 • 06:00 UTC
🇸🇪 Dagens Nyheter
National & Local

Claes Hultling: That's why we had a sex room at the Spinal Clinic

Claes Hultling, a 31-year-old anesthesiologist, reflects on his transformative experience as a patient after a life-changing injury and shares his innovative ideas for the treatment of spinal cord injuries.

Feb 20 • 05:19 UTC
🇧🇷 G1 (PT)
National & Local

Tatiana Sampaio, scientist who developed a molecule that can reverse spinal cord injuries, participates in event at IFTM in Patrocínio

Tatiana Sampaio, a leading researcher in spinal cord injury recovery, will participate in the 'Extraordinary Women' event at the IFTM in Patrocínio, Brazil.

Feb 18 • 17:58 UTC
🇬🇷 To Vima
National & Local

"Dancing Therapy" Restores Spinal Cord Injury in the Laboratory

Researchers at Northwestern University created the most detailed spinal cord model to date in the lab, inducing injury and subsequently treating it with 'dancing molecules.'

Feb 17 • 04:58 UTC
🇧🇷 G1 (PT)
Life & Tech

Polylaminin: a molecule discovered in Brazil 'by chance' that became hope to reverse spinal cord injuries

Polylaminin, a modified version of the naturally occurring laminin protein, is being studied as a new potential treatment for spinal cord injury victims in Brazil, although it is still in early clinical trial phases.

Feb 2 • 20:00 UTC
🇧🇷 Folha (PT)
Life & Tech

Podcast: the Brazilian experimental drug that may be hope for spinal cord injuries

The podcast discusses polylaminin, an experimental drug showing promise in restoring movement for patients with spinal cord injuries, highlighted by the case of a Brazilian influencer who regained arm movement after treatment.

Feb 2 • 08:00 UTC

Story in context

Loading Intelligence...

📡

Select a report from the feed to view analysis and related coverage.